Zobrazeno 1 - 10
of 17
pro vyhledávání: '"J L, Woolley"'
Publikováno v:
Journal of Travel Medicine. 6:S8-S12
Background: Safe and effective antimalarial drugs are needed for treatment and prophylaxis of malaria. The combination of atovaquone and proguanil hydrochloride is a new antimalarial drug combination that has recently become available in many countri
Publikováno v:
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology. 25(5)
A survey was carried out of 145 pregnant women in the third trimester in pregnancy to assess motivators to stop tobacco smoking and assess women's knowledge of fetal and maternal risk of smoking. In addition, the survey was to assess the acceptabilit
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 29(5)
P-Glycoprotein (Pgp) and cytochrome P450 3A (CYP3A) are important enzymes affecting the disposition of HIV protease inhibitors (HIV PIs). After multiple dosing experiments in rats, decreases in the plasma concentrations and area under plasma concentr
Autor:
J W, Polli, J L, Jarrett, S D, Studenberg, J E, Humphreys, S W, Dennis, K R, Brouwer, J L, Woolley
Publikováno v:
Pharmaceutical research. 16(8)
To determine the role of P-glycoprotein (Pgp) on the CNS penetration of the HIV protease inhibitor (PI) amprenavir (141W94) and to test the hypothesis that co-administration of a second HIV PI (ritonavir) could enhance amprenavir's brain penetration
Autor:
D. V. Deangelis, C. Thauvin-Eliopoulos, J. D. C. Yao, Robert C. Moellering, M L Grayson, J. L. Woolley, George M. Eliopoulos, L. Walton
Publikováno v:
Antimicrobial Agents and Chemotherapy. 34:1792-1794
To assess the potential efficacy of trimethoprim-sulfamethoxazole (TMP-SMX) against serious enterococcal infections, we used a rat enterococcal endocarditis model comparing TMP-SMX therapy (500 mg of TMP plus 2,500 mg of SMX per kg of body weight per
Publikováno v:
Biopharmaceuticsdrug disposition. 18(5)
1954U89, 1,3-diamino-7-(1-ethylpropyl)-8-methyl-7H-pyrrolo-(3, 2-f)quinazoline, is a potent, lipid-soluble inhibitor of dihydrofolate reductase. The pharmacokinetics and bioavailability of 1954U89 were examined in male beagle dogs and male CD rats. D
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 19(6)
The disposition of [14C]piritrexim ([14C]PTX) in male dogs after iv and po doses of 1.8 mg/kg was examined. After either route of administration, greater than 90% of the dose was recovered in the exreta within 72 hr; approximately 20% was recovered i
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 19(3)
The disposition of [14C]piritrexim in male rats after iv (5 and 10 mg/kg) and po (5, 10, and 20 mg/kg) doses was studied. After an iv dose of 10 mg/kg, rats excreted an average of 57% of the dose in feces and 32% in urine; after a po dose of 10 mg/kg
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 19(2)
Disposition and metabolism of crisnatol (14C-labeled), a novel antitumor agent, was examined after po and iv administration to rats. After both routes of drug administration, there was rapid elimination of the administered radioactivity in the urine
Publikováno v:
Clinical Pharmacology & Therapeutics. 75:P87
GR270773 (773) is a novel phospholipid emulsion with endotoxin binding activity. Alterations in dietary lipids have been shown to alter P450 activity. We therefore examined 773′s effects on protein content and activity of selected hepatic P450 enzy